This document provides an overview of venous thromboembolism (VTE) including deep vein thrombosis (DVT) and pulmonary embolism (PE). It discusses that VTE is a major cause of mortality and morbidity in the United States, killing over 200,000 people annually from PE alone. The document then reviews risk factors for VTE, treatment options including anticoagulation therapies and peripheral endovascular interventions, and indications for catheter-directed thrombolysis for acute massive PE.
Physician should have a high suspicion to diagnose patient with pulmonary Embolism, this slides will give you precise Diagnosis, Investigation and guideline directed Treatment.
Some slides are taken from different textbooks of medicine like Davidson, Kumar and Clark and Oxford, and some from other presentations made by respected tutors. I'm barely responsible for compilation of various resources per my interest. These resources are free for use, and I do not claim any copyright. Hoping knowledge remains free for all, forever.
Physician should have a high suspicion to diagnose patient with pulmonary Embolism, this slides will give you precise Diagnosis, Investigation and guideline directed Treatment.
Some slides are taken from different textbooks of medicine like Davidson, Kumar and Clark and Oxford, and some from other presentations made by respected tutors. I'm barely responsible for compilation of various resources per my interest. These resources are free for use, and I do not claim any copyright. Hoping knowledge remains free for all, forever.
Deep vein thrombosis (DVT) and Pulmonary embolism (PE)Aminul Haque
Deep vein thrombosis (DVT) and pulmonary embolism (PE), collectively referred to as venous thromboembolism (VTE), constitute a major global burden of disease.
Its a elaborate presentation on deep vein thrombosis by surgery resident.
Inform me if any thing needed to be correction.
thank you.
Dr Syed Aftub Uddin, MBBS,CCCD, MS ( Resident)
email: aftub_16@yahoo.com
Anticoagulation in Valvular Heart Disease.pptxzeinabnm
Brief definition with pathology, types, risk factors, clinical manifestation and staging in Valvular heart disease.
with detailed discussion of clinical management and approaches in different situation.
necessary information about each anti-coagulation used.
Deep vein thrombosis (DVT) & pulmonary embolism (PE). Life-threatening complications following trauma. Incidence of 5 to 63%. Risk factors: Pelvic and lower extremity fractures,Head injury and Prolonged immobilization. DVT prophylaxis is essential in the management of trauma patients.
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
More Related Content
Similar to 1320 1340 Venothromboembolic Diseases AGupta FINAL (1).pptx
Deep vein thrombosis (DVT) and Pulmonary embolism (PE)Aminul Haque
Deep vein thrombosis (DVT) and pulmonary embolism (PE), collectively referred to as venous thromboembolism (VTE), constitute a major global burden of disease.
Its a elaborate presentation on deep vein thrombosis by surgery resident.
Inform me if any thing needed to be correction.
thank you.
Dr Syed Aftub Uddin, MBBS,CCCD, MS ( Resident)
email: aftub_16@yahoo.com
Anticoagulation in Valvular Heart Disease.pptxzeinabnm
Brief definition with pathology, types, risk factors, clinical manifestation and staging in Valvular heart disease.
with detailed discussion of clinical management and approaches in different situation.
necessary information about each anti-coagulation used.
Deep vein thrombosis (DVT) & pulmonary embolism (PE). Life-threatening complications following trauma. Incidence of 5 to 63%. Risk factors: Pelvic and lower extremity fractures,Head injury and Prolonged immobilization. DVT prophylaxis is essential in the management of trauma patients.
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfJim Jacob Roy
Cardiac conduction defects can occur due to various causes.
Atrioventricular conduction blocks ( AV blocks ) are classified into 3 types.
This document describes the acute management of AV block.
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
1320 1340 Venothromboembolic Diseases AGupta FINAL (1).pptx
1. October 6, 2018
R E A C H I N G N E W H E I G H T S I N C A R D I O V A S C U LA R C A R E
2. A Primer on management of venous
thromboembolic disease.
Medical and endovascular options.
Ashish Gupta, MD, PhD
Interventional Cardiologist, Peripheral Vascular Disease
Specialist
Orlando Health Heart Institute Cardiology Group
Assistant Professor of Medicine, UCF College of Medicine.
3. VTE is a Spectrum of Disease
Not all VTE are created equally
Patients require individual assessment and management plans
4. VTE: A Major Source of Mortality and Morbidity
Over 200,000
deaths per year due to
PE annually in the
U.S. alone.
Over 600,000
patients diagnosed with
DVT annually in the US
alone
More than HIV,
MVAs & Breast
Cancer combined
10% of Hospital Deaths
most common
preventable death
Huge Costs
and Morbidity
Recurrence of DVT, post-
thrombotic syndrome and
chronic PE / PAH are long
term sequelae
Some Causes of Death in the US Annual Number of Deaths
PE Up to 200,000
AIDS 16,371
Breast Cancer 40,580
5. Venous Thromboembolism (VTE) remains a
major health problem
In addition to the risk of sudden death
30% of survivors
develop recurrent VTE
within 10 years
28% of survivors
develop venous stasis
syndrome within 20 years
5
7. VTE and the risk our patients face:
Age > 40
Immobility
CHF
Stroke
Paralysis
Spinal Cord injury
Hyperviscosity
Polycythemia
Severe COPD
Anesthesia
Obesity
Varicose Veins
Cancer
High estrogen states
Inflammatory Bowel
Nephrotic Syndrome
Sepsis
Smoking
Pregnancy
Thrombophilia
Surgery
Prior VTE
Central lines
Trauma
Most hospitalized patients have at least one risk factor for DVT
Stasis Hypercoagulability Endothelial
Damage
7
8. How do we treat VTE?
Who needs inpatient therapy?
9. Contraindications to outpatient treatment of
venous thromboembolism
Active or high risk of bleeding
Recent surgery (within 7 days)
Cardiopulmonary instability
Severe symptomatic venous obstruction
High risk pulmonary embolism*
Thrombocytopenia (platelets < 50,000/µL)
Other medical or surgical condition requiring inpatient management
Medical non-compliance
Geographical or telephone inaccessibility
Poor hepatic function (International Normalized Ratio (INR) ≥ 1.5)
Unstable renal function (e.g. rising serum creatinine)
Poor home health care support environment
10. Who needs inpatient Rx
• Suspected or proven concomitant PE
• Significant cardiovascular or pulmonary comorbidity
• Iliofemoral DVT, symptomatic distal calf DVT or UE axillary-
subclavian DVT
• Contraindications to anticoagulation
• Familial or inherited disorder of coagulation: antithrombin III (ATIII)
deficiency, prothrombin 20210A, protein C or protein S deficiency,
or factor V Leiden
• Familial bleeding disorder
• Pregnancy
• Morbid obesity (>150 kg)
• Renal failure (creatinine >2 mg/dL)
11. Rx is guided by underlying condition
Suggested Anticoagulant Regimen∗
Stage IV renal failure Prefer conventional treatment∗
Concomitant treatment with verapamil or
dronedarone
Prefer conventional treatment or rivaroxaban
Concomitant treatment with carbamazepine,
phenobarbital, phenytoin
Prefer conventional treatment
Active cancer LMWH or conventional treatment or NOACs
Isolated distal DVT If to be treated, prefer conventional treatment or LMWH or
NOACs
Unsuspected VTE If to be treated, treat as symptomatic VTE
Upper arm Treat as lower-limb VTE
Splanchnic or cerebral vein thrombosis Prefer conventional treatment
APLA Prefer conventional treatment
Patients with vena cava filter Prefer conventional treatment
12.
13.
14. NOACs and DVT
• Xarelto – Einstein-DVT trial 2010 – Non inferiority trial to
VKA
• Syvasa (Edoxaban) - Hokusai-VTE study - Non inferiority
trial to VKA
• Apixiban (Eliquis) – AMPLIFY trial – Non inferior to
Lovenox and VKA
• Pradaxa – REMEDY and RECOVER trial – Non inferior
to VKA
All trials required parenteral anticoagulation for 72h to
9d. Post thrombotic syndrome patients were NOT studied.
15. From: Diagnosis and management of acute deep vein thrombosis: a joint consensus document from the European society of cardiology working
groups of aorta and peripheral vascular diseases and pulmonary circulation and right ventricular function
Eur Heart J. Published online February 17, 2017.
17. Treatment of Venous Thromboembolism With New Anticoagulant
Agents - Practical tips
Follow-up patients on NOACs Check renal function and blood cell count at 1 month , then every 6 months
Switch from VKAs INR <2: NOACs can be initiated immediately
INR 2.0–2.5: better to start NOACs the next day
INR >2.5: take into account the actual INR value and the half-life of the VKA. A new
INR can be scheduled before starting the NOAC
Recurrent VTE on NOAC treatment Verify compliance to NOAC treatment
Reassess concomitant medications
Consider change to a different NOAC or to conventional treatment
Overdosing With active bleeding: Manage as patients with bleeding complications
In the absence of bleeding: Consider activated charcoal if <2 h
Withhold the next dose
Missing dose In bid regimens: take if <6 h from scheduled intake
In od regimens: take if <12 h from scheduled intake
18. Treatment of Distal DVT
• Serial imaging if no severe sxs for 2 weeks.
• OAC if there is extension of thrombus, or patient has
high risk for VTE.
19. Compression stockings for DVT
• No indication to prevent PTS
• Use only if patient has severe dependent edema.
20. Upper extremity DVT
• Axillary or more proximal veins: Anticoagulation is
preferred, however, CDT can be considered if bleeding
risk is low and there is access to CDT.
• Duration – three months
22. Endovascular management – Contemporary
data
• Three clinical trials in last 6 years
– TORPEDO trial - 2010, 183 patients with symptomatic DVT were randomized
to receive PEVI plus anticoagulation vs anticoagulation alone. At 30-month
follow-up recurrent VTE developed in 4.5% of the PEVI group vs 16% of the
control group (P=.02). PTS developed in 6.8% of the PEVI group vs 29.6% of
the control group (P<.001).
– Catheter-Directed Venous Thrombolysis in Acute Iliofemoral Vein Thrombosis
(CaVenT) trial - 2012, enrolled 209 patients. PTS was noted in 41.1% of the
CDT vs 55.6% of the control group at 24 months (P=.047). Ileofemoral patency
at 6 months was noted in 65.9% of the CDT vs 47.4% of the control group
(P=.012).
– The ATTRACT trial, a multicenter NHLBI study – no benefit in reducing PTS in
patients with femoral DVT. DID NOT STUDY MASSIVE ILIOFEMORAL DVTs
23. Peripheral endovascular intervention for
DVT (PEVI)
• Encompasses all modalities that can be employed for the
invasive diagnosis and treatment of venous disease when
performed through a percutaneous approach, which is the
usual practice. Includes:
– Catheter directed thrombolysis
– Pharmacomechanical thrombectomy,
– Balloon venoplasty, stenting, and imaging with intravascular ultrasound (IVUS).
24. Indications for PEVI
• Phlagmesia cerulea dolens
• IVC thrombosis
• Subacute and chronic iliofemoral DVTs
• Acute iliofemoral or femoropopliteal DVT treatment
27. 52y female with acute LLE extensive DVT
with 15y old filter
Caval Venoplasty followed by thrombectomy and stenting to crush
the old fractured filter to improve venous outflow
28. Day 2 – LLE PEVI
Thrombectomy using PENUMBRA device with complete restoration of antegrade flow and
resolution of LLE edema
39. 39
Metaanalysis showed consistent recovery of
hemodynamics among patients treated using
EKOS®
―
First author and year of
publication
No. of
patients
Patients with
high-risk PE
Total rt-PA
dose (mg)
Total
thrombolysis
duration (h)
RV/LV ratio
Mean pulmonary artery
pressure (mmHg)
40. 40
Metaanalysis demonstrated a favorable safety
profile among patients treated using EKOS®
−
First author and year of
publication
No. of
patients
Patients with
high-risk PE
Total rt-PA
dose (mg)
Total thrombolysis
duration (h)
Bleeding Complications Mortality at 3
months
41. Sub segmental PE
• In patients with subsegmental PE (no involvement of
more proximal pulmonary arteries) and no proximal
DVT in the legs who have:
• low risk for recurrent VTE - Clinical surveillance
• High risk for recurrent VTE – anticoagulation.
42. EKOS catheter directed thrombolysis for PE
Thrombus in
pulmonary arteries
Right Left
EKOS catheter in each PA
Editor's Notes
http://www.acphospitalist.org
Figure 2 Proposed deep vein thrombosis diagnostic and management algorithm. AC, anticoagulation; DOAC, direct oral anticoagulant.
If you look at the PE population you’ll see that 55% develop a low-risk, minor PE. The prognosis for this group is good and is associated with a low mortality rate. Minor or low-risk PE is of no consequence, and the focus should be to identify and treat the area where the clot originated, a possible DVT, as we discussed in the last slide.
Statistically, 5% are considered the high-risk or massive PE. This is the unstable, hypotensive, intubated patient that is most likely experiencing hemodynamic collapse. The prognosis for these patients is not good, with an extremely high mortality rate of 58% at 90 days. These patients typically receive the standard 100mg of IV tPA over two hours. We will talk about the risks associated with this approach later.
The remaining 40% of PE patients are considered the moderate or intermediate risk submassive PE. This patient presents symptomatically, is hemodynamically stable, but has right ventricular strain and dysfunction. The prognosis for this group remains under debate, and treatment for this subset of PE remains controversial. The mortality rate for this group ranges from 2-3% to 21% at 90 days, depending on the study. Given the mortality rates and the long term sequela associated with these patients, it is worth taking a closer look at treatment strategies and options.